DrugPatentWatch Database Preview
Drugs in Development Information for SGS-742
» See Plans and Pricing
What is the drug development status for SGS-742?
SGS-742 is an investigational drug.
There have been 3 clinical trials for SGS-742.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2013.
The most common disease conditions in clinical trials are Sclerosis, Lupus Erythematosus, Systemic, and Motor Neuron Disease. The leading clinical trial sponsors are University of Bari, Azienda Ospedaliero-Universitaria di Modena, and GlaxoSmithKline.
Summary for SGS-742
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 226 |
| WIPO Patent Applications | 159 |
| Japanese Patent Applications | 96 |
| Clinical Trial Progress | Phase 1 (2013-12-01) |
| Vendors | 0 |
Recent Clinical Trials for SGS-742
| Title | Sponsor | Phase |
|---|---|---|
| Colchicine for Amyotrophic Lateral Sclerosis | Catholic University of the Sacred Heart | Phase 2 |
| Colchicine for Amyotrophic Lateral Sclerosis | IRCCS National Neurological Institute "C. Mondino" Foundation | Phase 2 |
| Colchicine for Amyotrophic Lateral Sclerosis | IRCCS San Raffaele | Phase 2 |
Clinical Trial Summary for SGS-742
Top disease conditions for SGS-742
Top clinical trial sponsors for SGS-742
US Patents for SGS-742
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
